Suntrust Banks’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Suntrust Banks's RARE Position: Q3 2019 in Review
Suntrust Banks increased its Ultragenyx Pharmaceutical (RARE) stake by 3% in Q3 2019, buying an estimated $7.99K and bringing the position to 4,990 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #1240.
Suntrust Banks first reported a position in RARE in Q1 2019 and has held it in 3 quarters since. The position peaked at $319K in Q1 2019. 173 funds tracked by Wall St. Rank hold RARE as of Q3 2019.
- Suntrust Banks held 4,990 shares of Ultragenyx Pharmaceutical worth $213K as of Q3 2019.
- Suntrust Banks bought 147 Ultragenyx Pharmaceutical shares in Q3 2019, an estimated $7.99K.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #1240 holding.
- Suntrust Banks first reported a position in Ultragenyx Pharmaceutical in Q1 2019 and has held it in 3 quarters since.
- Suntrust Banks's Ultragenyx Pharmaceutical position peaked at $319K in Q1 2019.
- 173 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2019.
Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.